FDA Approved: NITROGLYCERIN — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

FDA approved a supplemental application for nitroglycerin submitted by Prasco Laboratories under the existing NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• NITROGLYCERIN (Nitroglycerin)

Snippet

SUPPL AP for NITROGLYCERIN (NITROGLYCERIN)